EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Beyond the Gut: Brain Fog, Sleep Quality, Cognitive Function and Quality of Life in Celiac Disease

Canan Altinsoy iD, Evrim Kahramanoğlu Aksoy, Mehmet Raşit Ayte, Derya Dikmen

Nutrients · 19.07.2026 · 18 (14) · 2365

DOI: 10.3390/nu18142365 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Nutrients, online erschienen am 19.07.2026. Verfasst von Canan Altinsoy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Dietetics, Faculty of Health Sciences, Recep Tayyip Erdoğan University, 53350 Rize, Türkiye. Hauptthemen laut MEDLINE: Quality of Life, Celiac Disease, Cognition, Sleep Quality. Die Arbeit nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hacettepe University, Hacettepe University Scientific Research Projects Coordination Unit, Recep Tayyip Erdoğan University Development Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: This exploratory comparative cross-sectional observational study investigated brain fog symptoms, cognitive function, sleep quality, quality of life, and selected serum biomarkers related to inflammation and neurocognitive function in newly diagnosed patients with celiac disease (ND-CeD), patients with CeD on a gluten-free diet (GFD-CeD), and controls.

Methods

A total of 62 participants were included: ND-CeD patients (n = 18), GFD-CeD patients (n = 17), and healthy controls (n = 27) with no statistically significant differences in age or sex distribution across groups. Brain fog symptoms and severity, cognitive function, sleep quality, and quality of life were assessed using the Brain Fog Scale (BFS), Brain Fog Severity Score (BFSS), Montreal Cognitive Assessment (MoCA), Single-Item Sleep Quality Scale (SQS), and World Health Organization Quality of Life Questionnaire-Brief Form-TR (WHOQOL-BREF-TR), respectively. Serum BDNF, S100B, TLR4, IL-6, and nitric oxide (NO) levels were measured by ELISA.

Results

ND-CeD patients had higher BFSs and BFSSs and lower MoCA, SQS, and WHOQOL-BREF-TR scores than healthy controls (p < 0.05). GFD-CeD patients showed numerically intermediate or more favorable scores than ND-CeD patients in several outcomes; however, most differences from controls were not statistically significant. Compared with ND-CeD patients, GFD-CeD patients had higher WHOQOL-BREF-TR General Health, Psychological Health, and Social Relationships scores (p < 0.05). In exploratory within-group analyses, after correction for multiple comparisons, higher BFS scores were associated with poorer psychological health and lower MoCA scores, and higher MoCA scores were associated with better psychological and physical health domains, particularly in the ND-CeD group. In the adjusted regression model, older age, income status, and newly diagnosed disease status were independently associated with MoCA scores. No statistically detectable between-group differences were observed in serum IL-6, NO, BDNF, S100B, or TLR4 levels.

Conclusions

These preliminary findings suggest that brain fog symptoms, cognitive performance, sleep quality, and quality of life may deserve greater attention at diagnosis and during follow-up in celiac disease. Although GFD-CeD patients showed more favorable scores in some outcomes, these cross-sectional differences should not be interpreted as treatment-related improvement. Larger longitudinal studies with objective assessment of gluten-free diet adherence, disease activity, micronutrient status, sleep quality, and gut–brain axis-related biomarkers are needed to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeCeliac DiseaseCognitionSleep QualityHumansMaleFemaleCross-Sectional StudiesAdultBiomarkersMiddle AgedDiet, Gluten-FreeToll-Like Receptor 4Interleukin-6Brain-Derived Neurotrophic FactorNitric OxideSleep Wake Disorders

Stichwörter der Autor:innen

MoCAMontreal cognitive assessmentbrain fogceliac diseasecognitive functionsgut–brain axissleep quality

Substanzen

BiomarkersToll-Like Receptor 4Interleukin-6Brain-Derived Neurotrophic FactorNitric OxideTLR4 protein, human

Autor:innen und Institutionen

  • Department of Nutrition and Dietetics, Faculty of Health Sciences, Recep Tayyip Erdoğan University, 53350 Rize, Türkiye.
  • Department of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, 06230 Ankara, Türkiye.
  • Department of Gastroenterology, Ankara Atatürk Sanatoryum Training and Research Hospital, University of Health Sciences, 06290 Ankara, Türkiye.

ORCID-Profile: Canan Altinsoy

Förderung

  • Hacettepe University
  • Hacettepe University Scientific Research Projects Coordination Unit
  • Recep Tayyip Erdoğan University Development Foundation

Zitieren

APA

Altinsoy, C., Kahramanoğlu Aksoy, E., Ayte, M. R., & Dikmen, D. (2026). Beyond the Gut: Brain Fog, Sleep Quality, Cognitive Function and Quality of Life in Celiac Disease. Nutrients, 18(14), 2365. https://doi.org/10.3390/nu18142365

Vancouver

Altinsoy C, Kahramanoğlu Aksoy E, Ayte MR, Dikmen D. Beyond the Gut: Brain Fog, Sleep Quality, Cognitive Function and Quality of Life in Celiac Disease. Nutrients. 2026;18(14):2365. doi:10.3390/nu18142365

BibTeX
@article{Altinsoy2026,
  author = {Altinsoy, Canan and Kahramanoğlu Aksoy, Evrim and Ayte, Mehmet Raşit and Dikmen, Derya},
  title = {Beyond the Gut: Brain Fog, Sleep Quality, Cognitive Function and Quality of Life in Celiac Disease},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {14},
  pages = {2365},
  doi = {10.3390/nu18142365}
}
Kostenlos starten →